103 related articles for article (PubMed ID: 38754659)
1. Molecular recognition and interaction between human plasminogen Kringle 5 and A2M domain in human complement C5 by biospecific methods coupled with molecular dynamics simulation.
Dai X; Xue P; Bian L
Int J Biol Macromol; 2024 May; 270(Pt 1):132356. PubMed ID: 38754659
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition and binding between human plasminogen Kringle 5 and α-chain of human complement component C3b by frontal chromatography and dynamics simulation.
Dai X; Yang J; Lv L; Wang C; Bian L
J Chromatogr A; 2024 Mar; 1718():464673. PubMed ID: 38340457
[TBL] [Abstract][Full Text] [Related]
3. Investigation of binding mechanism for human plasminogen Kringle 5 with its potential receptor vWA1 domain in Cochlin by bio-specific technologies and molecular dynamic simulation.
Zhang J; Wang Z; Wang J; Zhang R; Dong X; Bian L
Bioorg Chem; 2022 Oct; 127():105989. PubMed ID: 35777236
[TBL] [Abstract][Full Text] [Related]
4. Human laminin α3 chain G1 domain is a receptor for plasminogen Kringle 5 on human endothelial cells by biological specificity technologies and molecular dynamic.
Zhang Y; Zhang R; Bai J; Liu W; Yang J; Bian L
J Chromatogr A; 2020 Jun; 1620():460986. PubMed ID: 32173023
[TBL] [Abstract][Full Text] [Related]
5. Screening, characterization and specific binding mechanism of aptamers against human plasminogen Kringle 5.
Duan M; Li K; Zhang L; Zhou Y; Bian L; Wang C
Bioorg Chem; 2023 Aug; 137():106579. PubMed ID: 37149949
[TBL] [Abstract][Full Text] [Related]
6. Binding of angiogenesis inhibitor kringle 5 to its specific ligands by frontal affinity chromatography.
Bian L; Li Q; Ji X
J Chromatogr A; 2015 Jul; 1401():42-51. PubMed ID: 25981289
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR.
Byeon IJ; Kelley RF; Mulkerrin MG; An SS; Llinás M
Biochemistry; 1995 Mar; 34(9):2739-50. PubMed ID: 7893685
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition and interaction between human plasminogen Kringle 5 and voltage-dependent anion channel-1 by biological specificity technologies and molecular dynamic simulation.
Zhang J; Wang K; Xue P; Chen X; Bian L
Biophys Chem; 2022 Jan; 280():106710. PubMed ID: 34741992
[TBL] [Abstract][Full Text] [Related]
9. Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy.
Thewes T; Constantine K; Byeon IJ; Llinás M
J Biol Chem; 1990 Mar; 265(7):3906-15. PubMed ID: 2105955
[TBL] [Abstract][Full Text] [Related]
10. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
11. Voltage-Dependent Anion Channel-1, a Possible Ligand of Plasminogen Kringle 5.
Liang YK; Bian LJ
PLoS One; 2016; 11(10):e0164834. PubMed ID: 27749918
[TBL] [Abstract][Full Text] [Related]
12. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
[TBL] [Abstract][Full Text] [Related]
14. Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site.
Motta A; Laursen RA; Llinás M; Tulinsky A; Park CH
Biochemistry; 1987 Jun; 26(13):3827-36. PubMed ID: 2820478
[TBL] [Abstract][Full Text] [Related]
15. Protein-ligand interactions in the lysine-binding site of plasminogen kringle 4 are different in crystal and solution. Electrostatic interactions studied by site-directed mutagenesis exclude Lys35 as an important acceptor in solution.
Nielsen PR; Einer-Jensen K; Holtet TL; Andersen BD; Poulsen FM; Thøgersen HC
Biochemistry; 1993 Dec; 32(48):13019-25. PubMed ID: 8241155
[TBL] [Abstract][Full Text] [Related]
16. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
[TBL] [Abstract][Full Text] [Related]
17. 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.
Byeon IJ; Kelley RF; Llinás M
Biochemistry; 1989 Nov; 28(24):9350-60. PubMed ID: 2558718
[TBL] [Abstract][Full Text] [Related]
18. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles.
An SS; Carreño C; Marti DN; Schaller J; Albericio F; Llinas M
Protein Sci; 1998 Sep; 7(9):1960-9. PubMed ID: 9761476
[TBL] [Abstract][Full Text] [Related]
19. 1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4.
Petros AM; Ramesh V; Llinás M
Biochemistry; 1989 Feb; 28(3):1368-76. PubMed ID: 2496756
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site.
Ramesh V; Petros AM; Llinás M; Tulinsky A; Park CH
J Mol Biol; 1987 Dec; 198(3):481-98. PubMed ID: 2828641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
